Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.7950 (-0.13%) ($3.7950 - $3.7950) on Wed. Jan. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.6% (three month average) | RSI | 41 | Latest Price | $3.7950(-0.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.5% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKG(81%) ARKK(81%) IWO(80%) SKYY(80%) | Factors Impacting CGEN price | CGEN will decline at least -2.3% in a week (0% probabilities). VIXM(-71%) VXX(-52%) UUP(-22%) UNG(-13%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.3% (StdDev 4.6%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.25(-291.04%) | Resistance Level | $4.2 | 5 Day Moving Average | $3.86(-1.68%) | 10 Day Moving Average | $4.02(-5.6%) | 20 Day Moving Average | $4.2(-9.64%) | To recent high | -47% | To recent low | 0% | Market Cap | $314m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |